1102 related articles for article (PubMed ID: 29181338)
1. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 modulates the balance between viral specific CD4
Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
[TBL] [Abstract][Full Text] [Related]
3. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.
Peng G; Li S; Wu W; Sun Z; Chen Y; Chen Z
Immunology; 2008 Jan; 123(1):57-65. PubMed ID: 17764450
[TBL] [Abstract][Full Text] [Related]
5. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
[TBL] [Abstract][Full Text] [Related]
6. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
7. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.
Liu S; Zhang Q; Shao X; Wang W; Zhang C; Jin Z
Int Immunopharmacol; 2017 Sep; 50():87-94. PubMed ID: 28644966
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
10. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
Zhou Y; Zhang H; Li Y
Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
[TBL] [Abstract][Full Text] [Related]
12. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
Ren FY; Jin H; Piao XX; Piao FS
World J Gastroenterol; 2007 Nov; 13(41):5440-5. PubMed ID: 17907286
[TBL] [Abstract][Full Text] [Related]
14. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.
Yang F; Yu X; Zhou C; Mao R; Zhu M; Zhu H; Ma Z; Mitra B; Zhao G; Huang Y; Guo H; Wang B; Zhang J
PLoS Pathog; 2019 Apr; 15(4):e1007690. PubMed ID: 30998767
[TBL] [Abstract][Full Text] [Related]
16. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.
Kennedy PTF; Sandalova E; Jo J; Gill U; Ushiro-Lumb I; Tan AT; Naik S; Foster GR; Bertoletti A
Gastroenterology; 2012 Sep; 143(3):637-645. PubMed ID: 22710188
[TBL] [Abstract][Full Text] [Related]
17. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.
Dong J; Yang XF; Wang LX; Wei X; Wang AH; Hao CQ; Shen HJ; Huang CX; Zhang Y; Lian JQ
Front Cell Infect Microbiol; 2017; 7():98. PubMed ID: 28401068
[TBL] [Abstract][Full Text] [Related]
19.
Sung PS; Park DJ; Kim JH; Han JW; Lee EB; Lee GW; Nam HC; Jang JW; Bae SH; Choi JY; Shin EC; Park SH; Yoon SK
Front Immunol; 2019; 10():1319. PubMed ID: 31244857
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-21 responses in patients with chronic hepatitis B.
Li J; Ren W; Ma W; Zhang J; Shi J; Qin C
J Interferon Cytokine Res; 2015 Feb; 35(2):134-42. PubMed ID: 25243706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
